Insider Trading & Ownership - Truitt Joseph

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Truitt Joseph
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-17
Purchase
2023-05-18
2:12 pm
Larimar Therapeutics Inc.LRMRTruitt Joseph
Director
2,750$3.73$10,2582,750
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-29
Option Award
2024-05-31
4:57 pm
N/A
2034-05-29
Larimar Therapeutics Inc.LRMRTruitt Joseph
Director
19,000$019,000
(Direct)
View
2023-05-09
Option Award
2023-05-11
4:29 pm
N/A
2033-05-09
Larimar Therapeutics Inc.LRMRTruitt Joseph
Director
8,300$08,300
(Direct)
View
2022-05-10
Option Award
2022-05-12
8:28 pm
N/A
2032-05-10
Larimar Therapeutics Inc.LRMRTruitt Joseph
Director
8,300$08,300
(Direct)
View
2021-05-12
Option Award
2021-05-20
08:48 am
N/A
2031-05-12
Larimar Therapeutics Inc.LRMRTruitt Joseph
Director
8,300$08,300
(Direct)
View
2020-12-02
Disposition
2020-12-02
09:45 am
N/A
2030-05-28
BIOSPECIFICS TECHNOLOGIES CORPBSTCTruitt Joseph
Chief Executive Officer
100,000$24.780
(Direct)
View
2020-05-28
Option Award(A)
2020-10-19
4:15 pm
N/A
2030-05-28
BIOSPECIFICS TECHNOLOGIES CORPBSTCTruitt Joseph
Chief Executive Officer
100,000$0100,000
(Direct)
View
2020-09-29
Option Award
2020-09-30
2:00 pm
N/A
2030-07-16
Larimar Therapeutics Inc.LRMRTruitt Joseph
Director
16,600$016,600
(Direct)
View
2020-05-28
Option Award
2020-05-29
2:32 pm
N/A
2030-05-28
BIOSPECIFICS TECHNOLOGIES CORPBSTCTruitt Joseph
Chief Executive Officer
130,000$0130,000
(Direct)
View
2020-01-28
Disposition
2020-01-29
4:15 pm
N/A
2026-01-20
ACHILLION PHARMACEUTICALS INCACHNTruitt Joseph
Chief Executive Officer
2,892,766$00
(Direct)
View
2020-01-28
Disposition
2020-01-29
4:15 pm
N/A
N/A
ACHILLION PHARMACEUTICALS INCACHNTruitt Joseph
Chief Executive Officer
3,500$6.30
(Direct)
View
(A) Indicate amendment filing.